Dennis Slamon

Award Winner

1948 –

80

Who is Dennis Slamon?

Dennis Joseph Slamon, is an American oncologist and chief of the division of Hematology-Oncology at UCLA. He is best known for his work identifying the HER2/neu oncogene that is amplified in 25-33% of breast cancer patients and the resulting treatment Herceptin.

Slamon is the son of a West Virginia coal miner. He attended Washington & Jefferson College for its pre-med program.

He currently serves as director of Clinical/Translational Research at UCLA's Jonsson Comprehensive Cancer Center, and as director of the Revlon/UCLA Women's Cancer Research Program at JCCC. He is a professor of medicine, chief of the Division of Hematology/Oncology and executive vice chair for research for UCLA's Department of Medicine. Slamon also serves as director of the medical advisory board for the National Colorectal Cancer Research Alliance, a fund-raising organization that promotes advances in colorectal cancer.

For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the development of the new breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients.

We need you!

Help us build the largest biographies collection on the web!

Born
Aug 8, 1948
New Castle
Also known as
  • Dennis Joseph Slamon
Nationality
  • United States of America
Profession
Education
  • University of Chicago
Employment
  • UCLA Jonsson Comprehensive Cancer Center

Submitted
on July 23, 2013

Citation

Use the citation below to add to a bibliography:

Style:MLAChicagoAPA

"Dennis Slamon." Biographies.net. STANDS4 LLC, 2024. Web. 28 Mar. 2024. <https://www.biographies.net/people/en/dennis_slamon>.

Discuss this Dennis Slamon biography with the community:

0 Comments

    Browse Biographies.net